Osteoarthritis Another Health Detriment Of Obesity
The escalating obesity epidemic in the United States has focused attention on obesity as a risk factor for coronary artery disease, type 2 diabetes, and hypertension. But being overweight is also a risk factor for osteoarthritis (OA), the degeneration of the cartilage at the ends of bones, which results in painful and restricted movement, said an expert at the 55th Annual Meeting of the American College of Sports Medicine.
CombinatoRx Completes Enrollment In Phase 2B Clinical Trial Of CRx-102 In Knee Osteoarthritis
CombinatoRx, Incorporated (NASDAQ: CRXX) announced that it has completed patient enrollment in COMET-1 (CRx-102 Osteoarthritis Multi-center Evaluation Trial), the Company's Phase 2b clinical trial designed to evaluate the safety and efficacy of CRx-102 in subjects with symptomatic knee osteoarthritis.
Abbott's HUMIRA adalimumab Recommended By NICE For The Treatment Of Severe Active Ankylosing Spondylitis
HUMIRA (adalimumab) has been recommended by The National Institute for Health and Clinical Excellence (NICE) as one of the treatment options for adults with severe active ankylosing spondylitis (AS).[i] This is the first time that NICE has reviewed anti-TNF (anti-tumour necrosis factor) therapies for AS.
Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial Of Novel Bone Disease Therapy
Velcura Therapeutics, Inc. announced the successful completion of a first-in-man clinical trial for its lead compound, VEL-0230, which the company is investigating as a treatment for Rheumatoid Arthritis (RA) and other bone diseases. In extensive preclinical studies, VEL-0230 proved to be a powerful anti-inflammatory agent that also stimulates bone formation and inhibits bone loss.
Prestigious Janssen Award Received By Researchers Who Helped Millions With Arthritis
Two British researchers who pioneered treatments which have helped millions of people with rheumatoid arthritis and other autoimmune diseases have been awarded the prestigious 2008 Dr. Paul Janssen Award for Biomedical Research.
Breastfeeding And Arthritis
"Breast feeding your baby for at least a year can dramatically reduce the chance of contracting rheumatoid arthritis", the Daily Express reported. It went on to say that a study has found that women who breastfeed their babies for more than 13 months are half as likely to develop rheumatoid arthritis as women who don't.
Better Treatment For Autoimmune Diseases Could Result From Sugar Linkage
Researchers at the University of New Hampshire Glycomics Center have helped identify a specific carbohydrate structure that confers anti-inflammatory activity to a glycoprotein antibody that could lead to improved treatment of autoimmune diseases like lupus or rheumatoid arthritis.
Breastfeeding Reduces Risk Of Rheumatoid Arthritis
Women who breast feed for a longer period of time are less likely toget rheumatoid arthritis, according to a study published on May 13, 2008 in the Annals of the Rheumatic Diseases, a BMJ Specialist journal.In the last thirty years, the fraction of women breastfeeding for morethan six months has increased substantially.
Majority Of Congress Supports Passage Of Arthritis Bill
The Arthritis Foundation applauds 274 members of Congress for co-sponsoring the Arthritis Prevention, Control, and Cure Act, S. 626/H.R. 1283. As of today, 53 senators and 221 representatives have shown leadership by co-sponsoring this landmark legislation.
Alcohol Consumption Lowers Risk Of Rheumatoid Arthritis
Alcohol consumption has been linked with a decrease in risk ofdeveloping rheumatoid arthritis, according to an article released onJune 5, 2008 in the BMJ specialist journal Annals of theRheumatic Diseases. Arthritis is a disease that involves damage to the joints of the body.